click below
click below
Normal Size Small Size show me how
Child-resistant lids
Poison Prevention Packaging Act of 1970
| Drug or drug component | Answer |
|---|---|
| Aspirin | any aspirin-containing preparations |
| Methyl Salicylate (oil of wintergreen) | liquid preparations containing more than 5% by weight unless packaged in pressurized spray containers |
| Methyl Alcohol (methanol) | household substances in liquid form containing 4% or more by weight unless packaged in a pressurized spray container |
| Iron-containing drugs | containing a total amount of elemental iron equivalent to 250 mg |
| with the exception of those preparations in which iron is present solely as a colorant, dietary supplements that contain an equivalent of ___ or more of elemental iron in a single package | 250 mg |
| APAP | containing more than 1g in a single package |
| APAP exemptions to child-resistant lids | effervescent tablets or granules containing less than 10% APAP with a medial lethal dose greater than 5g/kg of body weight and that release at least 85 mL of CO2/grain when placed in water; unflavored APAP other than those for pediatrics packed w/ no more than 13 grains/unit dose and have no other substance subject to special packaging requirements |
| Diphenhydramine HCL | containing more than 66 mg in a single package |
| Ibuprofen | containing 1g or more in a single package |
| Loperamide | containing more than 0.045 mg in a single package |
| Lidocaine | containing more than 5 mg in a single package (includes all dosage forms including creams, sprays, and transdermal patches) |
| Dibucaine | products containing more than 0.5 mg in a single package (includes all dosage forms including creams, sprays, and transdermal patches) |
| Naproxen | containing 250 mg or more in a single package |
| Ketoprofen | containing more than 50 mg in a single package |
| Fluoride | containing more than 50 mg of elemental and more than 0.5% in a single package |
| Minoxidil | containing more than 14 mg in a single package (including topical products that must continue to meet requirements once applicator is installed by consumer |
| Imidazoline | product containing more than 0.08 mg or more in a single package. Drug class includes tetrahydrozoline, naphazoline, oxymetazoline, and xylometazoline often found in ophthalmic and nasal products |
| Any drug switched from Rx to ____ status | OTC |
| Exemption to child-resistant lid: request by _____ or _____ | patient; physician; *Prescriber can only request a non-child-resistant container on an individual prescription and not required to be in writing |
| Exemption to child-resistant lid: ____ containers not intended for household use | Bulk |
| Exemption to child-resistant lid: one package size of ___ drugs designed for the elderly | OTC |
| Specific Rx and non-Rx drug exemptions include: oral ______, conjugated ______, and northindrone acetate in manufacturer's package | contraceptives; estrogens |
| Specific Rx and non-Rx drug exemptions include: _____ acetate tablets | Medroxyprogesterone |
| Specific Rx and non-Rx drug exemptions include: Sublingual _____ and sublingual and chewable Isosorbide dinitrate of ____ mg or less | Nitroglycerin; 10 |
| Specific Rx and non-Rx drug exemptions include: _____ and ______ in effervescent tablets or granules | Aspirin and APAP |
| Specific Rx and non-Rx drug exemptions include: K+ supplements in ___-____ packaging | unit-dose |
| Specific Rx and non-Rx drug exemptions include: Sodium Fluoride containing no more than _____ mg of sodium fluoride per package | 264 mg |
| Specific Rx and non-Rx drug exemptions include: Anhydrous cholestyramine and ________ package | colestipol |
| Specific Rx and non-Rx drug exemptions include: Erythromycin ethylsuccinate granules for oral suspension and oral suspension in packages containing no more than ___ g of erythromycin | 8 |
| Specific Rx and non-Rx drug exemptions include: Erythromycin ethylsuccinate tablets in pacakges containing no more than ___ g of erythromycin | 16 |
| Specific Rx and non-Rx drug exemptions include: prednisone tablets containing no more than ____ mg per package | 105 |
| Specific Rx and non-Rx drug exemptions include: Methylprednisolone tablets containing no more than ___ mg per package | 84 |
| Specific Rx and non-Rx drug exemptions include: Mebendazole tablets containing no more than ____ mg per package | 600 |
| Specific Rx and non-Rx drug exemptions include: Betamethasone tablets containing no more than ____ mg per package | 12.6 |
| Specific Rx and non-Rx drug exemptions include: Preparations in aerosol containers intended for ______ | inhalation |
| Specific Rx and non-Rx drug exemptions include: _______ preparations | pancrealipase |
| Specific Rx and non-Rx drug exemptions include: Sucrose preparations in a solution of ______ and _______ | glycerol and water |
| Specific Rx and non-Rx drug exemptions include: Hormone replacement therapy products that rely solely upon the activity of one or more ______ or ______ substances | progestogen or estrogen |
| Specific Rx and non-Rx drug exemptions include: Colesevelam hydrochloride in powder form in packages containing not more than _____ g of the drug | 3.75 |
| Specific Rx and non-Rx drug exemptions include: Sevelamer carbonate in powder form in packages containing not more than ____ g of the drug | 2.4 |
| The Poison Prevention Packaging Act of 1970 is administered by ____ ____ ___ ___ (CPSC) | Consumer Product Safety Commission |